Stock Earnings

Question 1

What are NovaBay Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), NovaBay Pharmaceuticals Inc has a total asset of $3, Net loss of $-8

Question 2

What are the key financial ratios for NBY?

Accepted Answer

NovaBay Pharmaceuticals Inc's Current ratio is 1, has a Net margin is -88.88, sales per share of $2.65.

Question 3

How is NovaBay Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

NovaBay Pharmaceuticals Inc largest revenue segment is Eyecare & Wound Care, at a revenue of 11,174,000 in the most earnings release.For geography, United States is the primary market for NovaBay Pharmaceuticals Inc, at a revenue of 14,726,000.

Question 4

Is NovaBay Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, NovaBay Pharmaceuticals Inc has a net loss of $-8

Question 5

Does NovaBay Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, NovaBay Pharmaceuticals Inc has liability of 3

Question 6

How many outstanding shares for NovaBay Pharmaceuticals Inc?

Accepted Answer

NovaBay Pharmaceuticals Inc has a total outstanding shares of 4.88

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	--	9	14	14	8	9
Revenue Growth (YoY)	--	-36%	0%	75%	-11%	50%
Cost of Revenue	--	3	6	6	2	3
Gross Profit	--	6	7	7	5	5
Selling, General & Admin	--	11	12	15	12	12
Research & Development	--	0	0	0	0	0
Operating Expenses	--	11	12	15	12	12
Other Non Operating Income (Expenses)	--	-1	-1	0	-1	0
Pretax Income	--	-7	-9	-10	-5	-11
Income Tax Expense	--	--	--	0	0	0
Net Income	--	-8	-16	-16	-6	-11
Net Income Growth	--	-50%	0%	167%	-45%	10%
Shares Outstanding (Diluted)	--	3.39	0.12	1.61	1.25	1
Shares Change (YoY)	--	2,721%	-93%	28.99%	25%	61%
EPS (Diluted)	--	-2.53	-138.64	-10.1	-5.26	-11.02
EPS Growth	--	-98%	1,273%	92%	-52%	-35%
Free Cash Flow	-7	-5	-3	-6	-9	-4
Free Cash Flow Per Share	--	-1.47	-24.91	-3.72	-7.2	-4
Gross Margin	--	66.66%	50%	50%	62.5%	55.55%
Operating Margin	--	-44.44%	-35.71%	-50%	-75%	-66.66%
Profit Margin	--	-88.88%	-114.28%	-114.28%	-75%	-122.22%
Free Cash Flow Margin	--	-55.55%	-21.42%	-42.85%	-112.5%	-44.44%
EBITDA	--	-4	-5	-7	-6	-6
EBITDA Margin	--	-44.44%	-35.71%	-50%	-75%	-66.66%
D&A For EBITDA	0	0	0	0	0	0
EBIT	--	-4	-5	-7	-6	-6
EBIT Margin	--	-44.44%	-35.71%	-50%	-75%	-66.66%
Effective Tax Rate	--	--	--	0%	0%	0%

NovaBay Pharmaceuticals Inc (NBY) Price

NBY Stock Price Chart

NBY Income

Follow-Up Questions